Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Current Deferred Revenue: €0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:E9Q Guangdong Kanghua Healthcare Group Co Ltd FRA:E9Q
74 GF Score
Price €0.18
GF Value €0.20
! 2 Warning Signs
View Full Analysis

What is Guangdong Kanghua Healthcare Group Co Current Deferred Revenue?

Guangdong Kanghua Healthcare Group Co FRA:E9Q 74 Current Deferred Revenue is €0.0 Mil as of Jun. 2026. GuruFocus rates FRA:E9Q with a GF Score™ of 74/100 and a GF Value™ of €0.20. The stock has 2 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Guangdong Kanghua Healthcare Group Co's current deferred revenue for the quarter that ended in Jun. 2026 was €0.0 Mil.

Guangdong Kanghua Healthcare Group Co Current Deferred Revenue Related Terms

Guangdong Kanghua Healthcare Group Co Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Guangdong Kanghua Healthcare Group Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong Kanghua Healthcare Group Co Current Deferred Revenue Chart

Guangdong Kanghua Healthcare Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Guangdong Kanghua Healthcare Group Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:E9Q
74GF Score
Guangdong Kanghua Healthcare Group Co Ltd FRA:E9Q
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of €0.0 Mil mean?
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a Current Deferred Revenue of €0.0 Mil as of Jun. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors.
Is Guangdong Kanghua Healthcare Group Co's Current Deferred Revenue too high?
Guangdong Kanghua Healthcare Group Co's current Current Deferred Revenue is €0.0 Mil. Overall, Guangdong Kanghua Healthcare Group Co has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Guangdong Kanghua Healthcare Group Co's Current Deferred Revenue compare to HCA and THC?
Guangdong Kanghua Healthcare Group Co's Current Deferred Revenue of €0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. Guangdong Kanghua Healthcare Group Co's current Current Deferred Revenue is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Kanghua Healthcare Group Co stock overvalued right now?
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a current Current Deferred Revenue of €0.0 Mil. The stock's GF Value™ is €0.20, compared to a current price of €0.18 — trading 8% below its estimated fair value. The current Current Deferred Revenue is €0.0 Mil. Guangdong Kanghua Healthcare Group Co's overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Guangdong Kanghua Healthcare Group Co (FRA:E9Q), the current Current Deferred Revenue is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Overvalued in 2026?

Based on GuruFocus' analysis, Guangdong Kanghua Healthcare Group Co stock appears to be undervalued. The current stock price of €0.18 is trading 8% below its estimated GF Value™ of €0.20.

Key valuation signals for FRA:E9Q:

  • Current Deferred Revenue: €0.0 Mil
  • GF Value™: €0.20 vs. price of €0.18 (8% below fair value)
  • GF Score™: 74/100 with 2 warning signs

No single metric tells the full story. See the FRA:E9Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangdong Kanghua Healthcare Group Co Business Description

Other Exchanges 03689:Hong Kong
Address 1000 Dongguan Avenue, Guangdong Province, Dongguan, CHN
Guangdong Kanghua Healthcare Group Co Ltd provides healthcare services. The reportable segments are as follows, The Hospital services segment, which generates majority revenue, includes the provision of hospital services including inpatient healthcare services, outpatient healthcare services, and physical examination services; Rehabilitation and other healthcare services including the provision of rehabilitation services; Elderly healthcare services include the provision of elderly healthcare services, including assisted living, adult daycare, longterm care, residential care and hospice care to the aged patients; and Haemodialysis services segment is principally engaged in the operation of haemodialysis outpatient centres. It generates all of its revenue from the PRC.
74GF Score

Get the complete analysis for FRA:E9Q

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.18
Price
€0.20
GF Value